DISCOUNT-ZERTIFIKAT - NOVARTIS N Share Price

Certificat

DE000SU0DXA9

Market Closed - Deutsche Boerse AG 01:08:22 01/06/2024 am IST
82.99 EUR +0.53% Intraday chart for DISCOUNT-ZERTIFIKAT - NOVARTIS N
1 month+1.97%
3 months+0.90%
Date Price Change
31/24/31 82.99 +0.53%
30/24/30 82.55 +0.92%
29/24/29 81.8 +0.23%
28/24/28 81.61 -0.17%
27/24/27 81.75 +0.06%

Delayed Quote Deutsche Boerse AG

Last update May 01, 2024 at 01:08 am IST

More quotes

Static data

Product typeDiscount-Zertifikate
Buy / SellCALL
Underlying NOVARTIS AG
IssuerLogo Issuer Société Générale Société Générale
WKN SU0DXA
ISINDE000SU0DXA9
Date issued 06/10/2023
Maturity 21/03/2025 (292 Days)
Parity 1 : 1
Emission price 77.96
Emission volume N/A
Settlement Beides
Currency EUR

Technical Indicators

Highest since issue 85.49
Lowest since issue 76.77
Spread 0.13
Spread %0.16%

Company Profile

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%); - cardiovascular, renal and metabolic diseases (14.1%); - neuroscience (8.9%). The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products. At the end of 2023, Novartis AG had 33 production sites worldwide. Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
-
More about the company

Ratings for Novartis AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Novartis AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
103.1 USD
Average target price
108.8 USD
Spread / Average Target
+5.53%
Consensus